
Opinion|Videos|October 18, 2024
Safety and Efficacy of RSV Vaccines in Older Adults
Author(s)Carrie Koenigsfeld, PharmD, FAPhA
Key Takeaways
- ConquerRSV, AReSVi-006, and RENOIR trials show significant efficacy in preventing RSV-related illness in older adults.
- The vaccines have demonstrated generally well-tolerated safety profiles with manageable side effects.
Carrie Koenigsfeld, PharmD, FAPhA, discusses the RSV vaccines currently available for older adults, highlighting the efficacy and safety profiles of the ConquerRSV, AReSVi-006, and RENOIR trials.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Provide an overview of the RSV vaccines currently available for older adults, highlighting the efficacy and safety profiles of the ConquerRSV, AReSVi-006, and RENOIR trials.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
CKD Outcome Set Elevates Patient-Reported Measures
2
Preoperative GLP-1 Use Doesn't Change Bariatric Weight Loss Outcomes
3
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
4
Long-Lived Monocyte-Derived Cells Found to Support Lasting Lung Immunity Against Influenza
5



































































































